NBIX vs NRIX Stock Comparison
NBIX currently leads NRIX in this stock comparison, with AIQ scores of 74 vs 65. The clearest difference is risk resilience, while NRIX has the stronger value profile.
What is the main difference between NBIX and NRIX?
NBIX leads the current stock comparison as Neurocrine Biosciences, Inc., with the clearest separation coming from risk resilience and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Neurocrine Biosciences, Inc. vs Nurix Therapeutics, Inc.
NBIX leads
NBIX leads by 9 AIQ points, primarily on Risk Resilience and Momentum, having only recently taken the lead back from NRIX. Wall Street currently favors NRIX on target upside.
Fragile: 3 of 6 evidence groups support NBIX, the lead recently changed hands, and its current signal state is conflicted.
Neurocrine Biosciences, Inc.
Nurix Therapeutics, Inc.
The Algovestiq AIQ Score currently favors NBIX over NRIX, 74 versus 65 as of Nov 15, 2026. NBIX's advantage is driven primarily by stronger risk resilience and momentum, while NRIX holds the stronger value profile. NBIX also shows the stronger technical structure relative to its 50-day moving average, though analyst target upside currently favors NRIX. 3 of 6 covered evidence groups favor NBIX today, and the comparison is rated Fragile on stability: only 3 of 6 covered evidence groups agree. NBIX lead: Reversed — NRIX led by 10 AIQ points 30 sessions ago; NBIX now leads by 9.
Compare Neurocrine Biosciences, Inc. and Nurix Therapeutics, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price return from daily closes; distributions are not included.
Price return comparison
Growth of $10,000, price only
Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.
Compare NBIX and NRIX against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Risk Resilience69 vs 40NBIX +29
- Momentum70 vs 50NBIX +20
- Value77 vs 94NRIX +17
- Quality79 vs 78Even
3 of 6 evidence groups favor NBIX. NBIX’s edge is concentrated in risk resilience and momentum; NRIX keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.
Largest factor move: Value +1, not enough on its own to move the overall score.
New signals
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.7%)
Largest factor move: Value +1, not enough on its own to move the overall score.
No signal started or stopped since the prior session; its 5 active signals are unchanged.
NBIX's lead was unchanged in the latest session.
Deeper signal detail for each name lives on its own signals page — NBIX and NRIX both carry a full feed there.
The central trade-off
NBIX (Neurocrine Biosciences, Inc.): the stronger current systematic profile, led by risk resilience and momentum.
NRIX (Nurix Therapeutics, Inc.): the counter-case, on value, fundamentals, valuation — but at materially higher volatility, 145.5% against 55%.
The AIQ Score and Wall Street therefore point in different directions on this pair.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
NBIXNBIX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
NRIXNRIX on combined revenue and EPS growth.
Value
NRIXNRIX on the peer-relative Value factor, by 17 points.
Momentum
NBIXNBIX on the Momentum factor, by 20 points.
Lower downside
NBIXNBIX on Risk Resilience, by 29 points.
Analyst upside
NRIXNRIX on implied upside to the consensus price target.
AIQ vs Wall Street
The model and the Street disagree here: AIQ favors NBIX, analyst targets favor NRIX. That disagreement is the most useful thing on this page.
| Measure | NBIX | NRIX | Note |
|---|---|---|---|
| Implied upside to target | +23.5% | +117.2% | NRIX has more room |
| Target dispersion | +19.8% | +62.5% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 29 | 14 | Higher coverage generally improves confidence |
The two are measuring different things. The AIQ Score reads current fundamentals, valuation, trend and risk; analyst targets price forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something already priced in — it is worth resolving before acting on either.
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
3 of 6 covered evidence groups favor NBIX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | NBIX | 74 vs 65 |
| Fundamentals | NRIXon balance | revenue growth 17.1% vs 73.4%; EPS growth 42% vs 7.1%; TTM ROE 5.3% vs 56.8%; gross margin 97.8% vs 86.5%; operating margin 23.8% vs 41.3% — NRIX takes 3 of 5 decided legs, not all of them |
| Valuation | NRIX | Value 77 vs 94 |
| Technicals | NBIX | Price vs 50-day 12.7% vs -33.5%; vs 200-day 12.4% vs -23.1% |
| Risk Resilience | NBIX | Risk Resilience 69 vs 40 |
| Analyst expectations | NRIX | Target upside 23.5% vs 117.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of NBIX and NRIX and are excluded from the count.
AIQ Decision Stability
The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.
- The AIQ gap is moderate at 9 points.
- Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
- The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
- The lead has swung materially session to session. (argues the conclusion is provisional)
- The leader is throwing conflicting signals. (argues the conclusion is provisional)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on NBIX.
How the comparison changed
120 daily snapshots · May 27 – Nov 13NBIX lead: Reversed — NRIX led by 10 AIQ points 30 sessions ago; NBIX now leads by 9.
- Today
- NBIX +9
- 74 vs 65
- 7 sessions ago
- NRIX +3
- 71 vs 74
- 30 sessions ago
- NRIX +10
- 68 vs 78
- 90 sessions ago
- NBIX +18
- 74 vs 56
The lead changed hands 2 times in this window, most recently on Nov 10 when NBIX moved ahead of NRIX.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 2 bearish / 1 neutral, conflicted
Only NBIX
- Death Cross Active — bearish, trend, long horizon (0.20%)
- Drawdown Recovery Signal — bullish, risk_regime, long horizon (-14.7%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Bearish Divergence — bearish, momentum, medium horizon
- TRIX Bullish Signal — bullish, momentum, short horizon
2 bullish / 1 bearish / 2 neutral, conflicted
Only NRIX
- Golden Cross Active — bullish, trend, long horizon (15.60%)
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (9.92%)
- Keltner Channel Breakdown — bearish, volatility, short horizon
- RSI Oversold — bullish, momentum, short horizon
Both carry 1 more signal that do not separate them: ADX Trend Strengthening.
NBIX leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -1.18%, AIQ 0 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.77%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1NRIX closes the Risk Resilience gap — currently 29 points behind, the largest single contributor to NBIX's edge.
- 2NRIX's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it.
- 3NBIX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once.
- 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
NRIX leads on balance| Metric | NBIX | NRIX |
|---|---|---|
| Revenue growth (YoY) | 17.1% | 73.4% |
| EPS growth (YoY) | 42% | 7.1% |
| Gross margin | 97.8% | 86.5% |
| Operating margin | 23.8% | 41.3% |
| Return on equity (TTM) | 5.3% | 56.8% |
| Debt to equity | 0.1 | 0.07 |
Performance
NBIX leads 5 of 6 windows| Metric | NBIX | NRIX |
|---|---|---|
| 1 week (5 sessions) | 1.7% | 1.2% |
| 1 month (20 sessions) | 23.4% | -36.6% |
| 3 months (63 sessions) | 8.4% | -43% |
| 6 months (126 sessions) | 5.7% | -2.4% |
| Year to date | 18% | -18.4% |
| 1 year (252 sessions) | 14% | 27.2% |
Technicals
NBIX has the stronger structure| Metric | NBIX | NRIX |
|---|---|---|
| RSI (14) | 64.4 | 26.8 |
| ADX (14) | 33.6 | 35.9 |
| Price vs 50-day | 12.7% | -33.5% |
| Price vs 200-day | 12.4% | -23.1% |
| Volatility (1M, annualized) | 55% | 145.5% |
Risk
NBIX is the more resilient| Metric | NBIX | NRIX |
|---|---|---|
| Beta | 0.7 | 1.06 |
| Sharpe ratio | 0.49 | 0.64 |
| Sortino ratio | 0.72 | 0.87 |
| Max drawdown | -27.2% | -46.6% |
| Current drawdown | -9.8% | -44.3% |
| Annualized volatility | 35.2% | 67.3% |
| Value at risk (95%) | -3.4% | -4.8% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, NBIX or NRIX?
On the Algovestiq AIQ Score, NBIX is the stronger of the two as of Nov 15, 2026, scoring 74 against NRIX's 65. The edge comes from risk resilience and momentum. NRIX is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is NBIX or NRIX the better buy right now?
NBIX carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: only 3 of 6 covered evidence groups agree. Treat the lead as provisional.
Why does the AIQ Score favor NBIX over NRIX?
The composite weights Quality, Value, Momentum and Risk Resilience. NBIX leads Risk Resilience by 29 points; NBIX leads Momentum by 20 points; NRIX leads Value by 17 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, NBIX or NRIX?
Analyst price targets imply +23.5% upside for NBIX and +117.2% for NRIX, so the Street currently favors NRIX. That points the opposite way to the AIQ Score, which favors NBIX. The two are measuring different things: the model reads current fundamentals, valuation, trend and risk; the Street is pricing forward expectations. A divergence of this kind is either a contrarian opportunity or a sign the model is missing something the analysts have already priced — it is the single most useful row on this page to investigate. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, NBIX or NRIX?
NRIX is the better-valued of the two on the peer-relative Value factor. NRIX on the peer-relative Value factor, by 17 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, NBIX or NRIX?
NRIX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, NBIX or NRIX?
NBIX on the Momentum factor, by 20 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, NBIX or NRIX?
NBIX is the more resilient of the two, so the other name carries the higher downside risk. NBIX on Risk Resilience, by 29 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is NBIX more profitable than NRIX?
The profitability evidence is mixed: gross margin 97.8% vs 86.5%; operating margin 23.8% vs 41.3%; ttm roe 5.3% vs 56.8%. NBIX leads on one measure and NRIX on two measures, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is NBIX's lead over NRIX getting stronger or weaker?
NBIX lead: Reversed — NRIX led by 10 AIQ points 30 sessions ago; NBIX now leads by 9. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands 2 times in that window, most recently on 2026-11-10, when NBIX moved ahead of NRIX.
What would change the NBIX vs NRIX verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: NRIX closes the Risk Resilience gap — currently 29 points behind, the largest single contributor to NBIX's edge; NRIX's Keltner Channel Breakdown resolves — a bearish volatility rule currently active against it; NBIX's conflicting signal state resolves bearish — it currently carries 4 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.
What do the current signals say about NBIX and NRIX?
NBIX: 4 bullish / 2 bearish / 1 neutral, conflicted. NRIX: 2 bullish / 1 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on NBIX is Death Cross Active (bearish, long horizon). On NRIX it is Golden Cross Active (bullish, long horizon).
Compare NBIX and NRIX with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.